The fourth top 50 biotechnology innovation enterprises in Guangdong, Hong Kong and Macao Dawan district were released

2021 the 4th Guangdong Hong Kong Macao Dawan District top 50 biotechnology innovation enterprises selection and award ceremony and the 19th China Medical Industry Summit – biotechnology innovation and Development Summit were held in Nansha, Guangzhou recently. The conference announced the results of the top 50 selection, and released the report of the top 50 biotechnology innovation enterprises in Dawan district at the same time.

The conference was hosted by China Innovation Industry Research Institute and undertaken by Guangdong Medical valley. Shu Yuan, chairman of Zhongchuang group, said in his speech that biotechnology is one of the industries with the most development potential and the most fierce competition all over the world. The top 50 has been selected for four times, and we have also witnessed the rapid development of the enterprise. As an industrial financing docking platform between enterprises and investment institutions, the top 50 activities found that in recent years, high-quality enterprises in Guangdong, Hong Kong and Macao Bay have been sought after by the capital market, and the pace of enterprise listing and financing efficiency have accelerated. It can be seen that the top 50 enterprises have unique development advantages and will further develop into the backbone of the biotechnology industry in the bay area. With the support of the capital market, the biotechnology industry in the bay area will continue to maintain rapid development.

Wang Xiaorong, planning director of China Innovation Industry Research Institute, released the innovation report of top 50 biotechnology enterprises in Guangdong, Hong Kong and Macao. The innovation report of the top 50 biotechnology enterprises in Guangdong, Hong Kong and Macao Dawan district was written by China Innovation Industry Research Institute. The report makes statistics and detailed analysis on the top 50 enterprises. Among the top 50 enterprises shortlisted, most of them have their core business covering biomedicine, a total of 22, and about half of them are involved in biomedicine. As a very important part of the medical industry, in vitro diagnosis is applied in disease prevention, diagnostic testing and post-treatment evaluation. In vitro diagnostic devices have become the most concentrated subdivided device field of the shortlisted enterprises.

Awards were given to the top 50 enterprises on the spot. This list is composed of leading enterprise award, Pioneer Enterprise Award, cutting-edge enterprise award and best Popularity Award. At the same time, the most popular enterprise award of online voting was awarded.

(Shanghai Securities News · China Securities Network)

 

- Advertisment -